Gherghe Mirela, Lazar Alexandra Maria, Mutuleanu Mario-Demian, Stanciu Adina Elena, Martin Sorina
Nuclear Medicine Department, University of Medicine and Pharmacy Carol Davila Bucharest, 050474 Bucharest, Romania.
Nuclear Medicine Department, Institute of Oncology "Profesor Doctor Alexandru Trestioreanu", 022328 Bucharest, Romania.
Diagnostics (Basel). 2022 Feb 12;12(2):471. doi: 10.3390/diagnostics12020471.
We performed a systematic review of the literature to provide an overview of the application of PET-based radiomics of [F]FDG-avid thyroid incidentalomas and to discuss the additional value of PET volumetric parameters and radiomic features over clinical data.
The most relevant databases were explored using an algorithm constructed based on a combination of terms related to our subject and English-language articles published until October 2021 were considered. Among the 247 identified articles, 19 studies were screened for eligibility and 11 met the criteria, with 4 studies including radiomics analyses.
We summarized the available literature based on a study of PET volumetric parameters and radiomics. Ten articles provided accurate details about volumetric parameters and their prospective value in tumour assessment. We included the data provided by these articles in a sub-analysis, but could not obtain statistically relevant results. Four publications analyzed the diagnostic potential of radiomics and the possibility of creating precise predictive models, their corresponding quality score being assessed.
The use of PET volumetric parameters and radiomics analysis in patients with [F]FDG-avid thyroid incidentalomas outlines a great prospect in diagnosis and stratification of patients with malignant nodules and may represent a way of limiting the need for unnecessary invasive procedures; however, further studies need to be performed for a standardization of the method.
我们对文献进行了系统综述,以概述基于PET的[F]FDG摄取阳性甲状腺偶发瘤的放射组学应用,并讨论PET体积参数和放射组学特征相对于临床数据的附加价值。
使用基于与我们主题相关的术语组合构建的算法,对最相关的数据库进行检索,并纳入截至2021年10月发表的英文文章。在识别出的247篇文章中,筛选出19项研究的合格性,11项符合标准,其中4项研究包括放射组学分析。
我们基于对PET体积参数和放射组学的研究总结了现有文献。10篇文章提供了关于体积参数及其在肿瘤评估中的前瞻性价值的准确细节。我们将这些文章提供的数据纳入了一项亚分析,但未获得具有统计学意义的结果。4篇出版物分析了放射组学的诊断潜力以及创建精确预测模型的可能性,并对其相应的质量评分进行了评估。
在[F]FDG摄取阳性甲状腺偶发瘤患者中使用PET体积参数和放射组学分析,在恶性结节患者的诊断和分层方面展现出巨大前景,可能代表了一种限制不必要侵入性检查需求的方法;然而,需要进一步开展研究以实现该方法的标准化。